Stéphanie Forté: The Hidden Burden of Stroke in Adults Living with Sickle Cell Disease
Stéphanie Forté, Principal Researcher at the Innovation Hub at the CHUM Research Center (CRCHUM), shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Stroke and sickle cell disease: a Montreal study reveals lasting impacts on adults.
This Black History Month, British Journal of Hematology is releasing a study led by our team at CHUM – Montreal University Hospital Center, CHUM Research Center (CRCHUM) and University of Montreal that highlights a reality that is still under-recognized: stroke in adults living with sickle cell disease.
Sickle cell disease, also known as sickle cell disease, is a genetic blood disorder that primarily affects people of African and Caribbean descent.
While the risk of stroke is well documented in children, data in adults remain limited.
By analyzing the trajectories of 454 adults followed at the CHUM, we found that nearly 1 in 20 people had already suffered a stroke.
Importantly, these strokes do not only affect the most severe forms of the disease, but also forms that are sometimes perceived as ‘milder’.
The sequelae observed are often long-lasting:
- Difficulty with memory and concentration
- Loss of autonomy in daily activities
This study is the result of a multidisciplinary collaboration bringing together researchers in hematology, vascular neurology (ICranium) and the next generation of committed physicians.
Congratulations to Jonathan St-Onge, future hematology resident at the University of Montreal for his teamwork, perseverance and commitment to advancing care and research.
‘Sickle cell anemia accompanies people all their lives. Its neurological complications in adulthood remain underestimated and require increased attention.’
Our results highlight the importance of:
- better prevention of stroke in sickle cell disease
- rapid recognition of symptoms
- specialized follow-up adapted to adults
This publication is part of a broader effort to reduce health inequalities, a central issue of Black History Month.
Thank you to all the co-investigators who generously gave their time, expertise and energy! Christian Stapf, Gregory Jacquin, Olena Bereznyakova, Chrystelle Charles, Tzvetena Hristova, Olivier Pouliot, Janick Caron-Lecuyer, Costa Kazadi, Sara-Maude Desforges, Mia Stevanovik, Julián Alejandro Rivillas.
Thank you also to the members of the clinical and administrative team Sangre, in the hematology and oncology department of the CHUM, to patients, as well as to L’Association d’Anémie Falciforme du Québec AAFQ- The Sickle Cell Anemia Association of Quebec SCAAQ and the Foundation of the Montreal University Hospital Center (CHUM).”
Title: Stroke burden and functional impacts in adults with sickle cell disease.
Authors: Jonathan St-Onge, Tzvetena Hristova, Chrystelle Charles, Olena Bereznyakova, Gregory Jacquin, Olivier Pouliot, Janick Caron-Lecuyer, Mia Stevanovik, Sara-Maude Desforges, Costa M. Kazadi, Julian Alejandro Rivillas, Christian Stapf, Stéphanie Forté
Read the Full Article on British Journal of Hematology
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS